In vivo evolution of tumor cells after DNA damage
Author Information
Author(s): H Mekid, O Tounekti, A Spatz, M Cemazar, F Z El Kebir, L M Mir
Primary Institution: Institut Gustave-Roussy
Hypothesis
The study investigates how different numbers of double-strand DNA breaks (DSB) affect the cell death pathways in tumor cells in vivo.
Conclusion
The results indicate that the number of DSB generated by bleomycin influences whether tumor cells undergo mitotic cell death or pseudoapoptosis.
Supporting Evidence
- Cell death pathways were influenced by the number of double-strand DNA breaks.
- Bleomycin treatment led to rapid apoptotic changes in tumor cells.
- Electropermeabilization facilitated the uptake of bleomycin, enhancing its effectiveness.
Takeaway
When tumor cells are treated with a drug that damages their DNA, how they die depends on how much damage they get. Some cells die quickly, while others take longer.
Methodology
Tumor cells were treated with bleomycin and subjected to electropermeabilization, followed by histological analysis to assess cell death pathways.
Potential Biases
Potential bias in the interpretation of histological data and the influence of the immune response on tumor cell death.
Limitations
The study primarily focuses on two tumor types and may not generalize to all cancers.
Participant Demographics
C57Bl/6 female mice, 6–8 weeks old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website